Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Income (2016 - 2025)

Historic Operating Income for Neuroone Medical Technologies (NMTC) over the last 13 years, with Q4 2025 value amounting to -$1.7 million.

  • Neuroone Medical Technologies' Operating Income fell 19977.21% to -$1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.6 million, marking a year-over-year decrease of 1266.61%. This contributed to the annual value of -$4.2 million for FY2025, which is 6444.52% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Operating Income stood at -$1.7 million for Q4 2025, which was down 19977.21% from -$1.4 million recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Operating Income peaked at $1.7 million during Q4 2024, and registered a low of -$3.5 million during Q2 2023.
  • In the last 5 years, Neuroone Medical Technologies' Operating Income had a median value of -$2.8 million in 2022 and averaged -$2.4 million.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Operating Income skyrocketed by 15047.1% in 2024, and later crashed by 19977.21% in 2025.
  • Neuroone Medical Technologies' Operating Income (Quarter) stood at -$2.8 million in 2021, then skyrocketed by 36.48% to -$1.8 million in 2022, then plummeted by 90.01% to -$3.4 million in 2023, then surged by 150.47% to $1.7 million in 2024, then crashed by 199.77% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q4 2025, -$1.4 million for Q3 2025, and -$1.9 million during Q2 2025.